← All stocks

BMY vs GILD

Bristol-Myers Squibb Company Common Stock vs Gilead Sciences Inc. Common Stock. Side-by-side ACCE scores, valuation, profitability, and growth.

BMY
Bristol-Myers Squibb Company Common Stock
Healthcare
62.62
127.91B
GILD
Gilead Sciences Inc. Common Stock
Healthcare
150.56
186.13B
ACCE scores
BMY
GILD
Composite score
Out of 100
78
64
Growth
64
76
Value
88
40
Quality
83
55
Momentum
77
83
Valuation
BMY
GILD
Price
62.62
150.56
Market cap
127.91B
186.13B
Trailing P/E
13.79
0.00
Forward P/E
9.65
15.29
EV / EBITDA
9.68
116.03
Dividend yield
4.0%
2.1%
Profitability
BMY
GILD
ROE
46.6%
-20.7%
Net margin
18.9%
-10.6%
Debt / equity
2.44
1.10
Free cash flow
12.85B
9.46B
Growth
BMY
GILD
Revenue growth (YoY)
5.7%
10.2%
Earnings growth (YoY)
1.5%
54.8%
Analyst target
66.71
158.15
See full analysis